Moderna Inc (MRNA)
Moderna's stock faces regulatory hurdles as FDA refuses to review its seasonal flu vaccine, impacting price action amidst ongoing discussions about its pipeline and market performance.
About Moderna Inc
Moderna Inc. is a biotechnology company focused on drug discovery, drug development, and vaccine technologies based on messenger RNA (mRNA).
Moderna Inc uses the ticker $MRNA for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Moderna Inc (MRNA) trading volume is up 64.03% from the previous month.
- Moderna Inc (MRNA) creators is up 143.71% from the previous month.
- Moderna Inc (MRNA) engagements is up 54.85% from the previous week.
- Moderna Inc (MRNA) mentions is up 99.16% from the previous month.
- Moderna Inc (MRNA) posts created is up 103.59% from the previous week.
Price: $42.20
Price 24-Hour Time-Series Raw Data
Moderna's stock experienced a significant drop following the FDA's refusal to review its seasonal influenza vaccine application. While there's underlying interest in its pipeline and potential, the immediate price action is heavily influenced by this regulatory setback and associated volatility, with recent posts highlighting technical resistance levels and the need to break key trigger points for further upward movement.
24-Hour: -0.12% 7-Day: 3.19% 30-Day: 0.88%
1-Year High: $51.90 on 2026-01-22
1-Year Low: $22.40 on 2025-11-20
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Moderna Inc (MRNA) is currently AltRank #451 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +225
[--] Month: [---] +181
[--] Months: [---] +191
[--] Year: [---] +404
1-Year High: [-----] on 2025-07-19
1-Year Low: [--] on 2025-02-21
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] no change
[--] Month: [--] [---]
[--] Months: [--] +4
[--] Year: [--] +16
1-Year High: [--] on 2025-10-30
1-Year Low: [--] on 2026-02-14
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [---------] +55%
[--] Month: [---------] +54%
[--] Months: [----------] -7%
[--] Year: [----------] -52%
1-Year High: [-------] on 2025-05-29
1-Year Low: [-----] on 2025-12-25
Engagements by network (24h): YouTube: [--] TikTok: [--] X: [------] Reddit: [---]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] +25%
[--] Month: [-----] +99%
[--] Months: [------] +30%
[--] Year: [------] -37%
1-Year High: [-----] on 2025-08-27
1-Year Low: [---] on 2025-12-07
Mentions by network (24h): YouTube: [--] TikTok: [--] X: [---] Reddit: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Moderna Inc (MRNA) in the last [--] hours which is down 25% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [-----] +19%
[--] Month: [-----] +144%
[--] Months: [------] +138%
[--] Year: [------] +142%
1-Year High: [-----] on 2025-08-27
1-Year Low: [--] on 2025-12-07
The most influential creators that mention Moderna Inc in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @earnings_guy | [--] | [------] | [--] | [-----] |
| @ABTradess | [--] | [------] | [--] | [-----] |
| @ricpuglisi | [--] | [------] | [--] | [-----] |
| @WealthyReadings | [--] | [------] | [--] | [-----] |
| @AmeliaVilla | [--] | [--] | [--] | [---] |
| @adamfeuerstein | [--] | [-------] | [--] | [---] |
| @eWhispers | [--] | [-------] | [--] | [---] |
| @tig88411109 | [--] | [------] | [--] | [---] |
| @abdulsalam1428 | [--] | [------] | [--] | [---] |
| @moderna_tx | [--] | [------] | [--] | [---] |
Sentiment: 68%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 68%
Daily Average: 77%
[--] Week: 33% -29%
[--] Month: 62% -13%
[--] Months: 62% -27%
[--] Year: 62% -11%
1-Year High: 97% on 2025-10-26
1-Year Low: 23% on 2025-05-29
Most Supportive Themes:
- Positive Price Movement and Pipeline Potential: (40%) Moderna's stock is showing positive price action, with analysts and social media users highlighting its strong pipeline and potential for significant growth, especially in areas like AI-driven personalized cancer vaccines.
- Analyst and Trader Interest: (30%) Traders and analysts are actively discussing Moderna's stock, with many sharing technical analysis, price targets, and swing trade opportunities, indicating a high level of interest in its short-term and long-term prospects.
- Market Performance and Sector Strength: (20%) Moderna is being recognized for its performance within the healthcare sector, with mentions of its stock surging and being part of 'Early Morning Movers Bullish' scans, suggesting it's a notable player in the current market.
Most Critical Themes:
- Volatility and Resistance Levels: (70%) While positive, some posts highlight that Moderna is facing major trend resistance and that further significant moves depend on breaking key trigger points, suggesting potential for volatility.
- Economic Uncertainty and Diversification: (30%) Some social posts link Moderna to broader economic concerns and suggest diversification away from traditional stocks and cryptos, implying a cautious sentiment among a segment of the market.
Social Dominance: 0.033%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.033%
Daily Average: 0.103%
[--] Week: 0.036% -0.017%
[--] Month: 0.065% -0.01%
[--] Months: 0.065% -0.096%
[--] Year: 0.065% -0.209%
1-Year High: 0.295% on 2025-02-18
1-Year Low: 0.019% on 2025-12-07
Market Dominance: 0.019%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.019%
Daily Average: 0%
1-Year High: 0.027% on 2025-03-12
1-Year Low: 0.011% on 2025-11-20
Market Cap: $16,481,144,766
Market Cap 24-Hour Time-Series Raw Data
Current Value: $16,481,144,766
Daily Average: $11,525,599,727
[--] Week: $16,481,144,766 -0.05%
[--] Month: $16,481,144,766 +0.84%
[--] Months: $16,481,144,766 +62%
[--] Year: $16,481,144,766 +29%
1-Year High: $20,267,353,699 on 2026-01-22
1-Year Low: $8,736,804,101 on 2025-11-20
Top Moderna Inc Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$MRNA -Citi raises Moderna target to $41 from $28 Neutral -UBS raises target to $36 from $34 Neutral -Morgan Stanley raises target to $30 from $28 = Weight -"
X Link @MarcJacksonLA 2026-02-16T23:36Z [----] followers, [---] engagements
"As $MRNA useless #vaccine is crushed by #FDA #PresidentsDay week rally+inflows 🚀are COMING 📈 to REAL #transformative treatments using #genetherapy #baseEditing #primeEditing #carT #TIL via $CRSP $BEAM $NTLA $EDIT $PRME $QURE $SRPT $RGNX $LEGN $allo $crbu $IOVA $DNA $arkG $XBI @drjohnm Bravo @VPrasadMDMPH #FDA. Please focus on real #transformative #unmet needs curable #geneTherapy #CRISPR #baseEditing #primeEditing $XBI https://t.co/qSboFHlrHO @drjohnm Bravo @VPrasadMDMPH #FDA. Please focus on real #transformative #unmet needs curable #geneTherapy #CRISPR #baseEditing #primeEditing $XBI"
X Link @BRSreality 2026-02-16T20:46Z [---] followers, [---] engagements
"$mrna may want to relocate to Europe.or China. That would send a signal. Recently quite a bit of news here in Germany about mRNA hostility in the US. Could be a rare opening. Biontech/Curevac already here"
X Link @RNAiAnalyst 2026-02-16T20:14Z 21.2K followers, [----] engagements
"Prasad is soooo unbiased at FDA People will love to invest into US pharma companies $mrna That is reassuring EXCEPT that after Prasad overruled the review team to issue a RTF the HEAD OF VACCINES at FDA wrote a memo to challenge VP's decision @RxRegA stop trying to gaslight people with your tribal takes https://t.co/Nj3RBwDemL https://t.co/4g6XTlybP2 That is reassuring EXCEPT that after Prasad overruled the review team to issue a RTF the HEAD OF VACCINES at FDA wrote a memo to challenge VP's decision @RxRegA stop trying to gaslight people with your tribal takes https://t.co/Nj3RBwDemL"
X Link @ricpuglisi 2026-02-16T18:09Z 95.3K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing